Why Women Live Longer : the Cell Biology of Sex-Based Aging

In virtually every country in the world, women live longer than men. In France, the gap is approximately six years. In Japan, it exceeds seven years. In some regions of the world, it reaches ten years.

For a long time, this gap was attributed to behavioral factors: men smoke more, take more risks, consult doctors less. These explanations are partially accurate. But they are insufficient.

Contemporary geroscience has accumulated a body of data pointing toward a more fundamental reality: men and women age differently at the cellular and molecular level. The differences traverse the epigenome, mitochondrial metabolism, immunology, hormonal regulation and the response to oxidative stress.

The longevity gap: beyond behavior

Studies on cloistered religious populations — monks and nuns living in comparable environments — show that the longevity gap persists, attenuated but not erased.

Studies on centenarian populations reveal a striking asymmetry: women represent approximately 80% of centenarians in most developed countries. Among supercentenarians (110 years and older), the proportion exceeds 90%.

These data suggest that exceptional longevity is biologically biased in favor of women — a bias that behavioral differences alone cannot explain.

Sex chromosomes: a fundamental biological asymmetry

Women have two X chromosomes (XX), men one X and one Y chromosome (XY).

The genetic redundancy of the X chromosome. In women, if a gene on the first X chromosome is mutated, its homologue on the second X chromosome can compensate. This redundancy does not exist in men. Many genes involved in DNA repair, immune response and cellular metabolism are located on the X chromosome. Women benefit from a "genetic insurance" that men do not have.

The Y chromosome and its progressive erosion. Research by Lars Forsberg in Sweden showed that somatic loss of the Y chromosome in hematopoietic cells — a phenomenon that increases with age in men — is associated with reduced life expectancy and increased risk of cardiovascular disease and cancers. This loss is now considered a biomarker of male aging.

Mitochondria: a maternal link to longevity

Mitochondrial DNA is transmitted exclusively through the maternal line. The embryo's mitochondria come entirely from the maternal oocyte.

Several researchers have developed the "mother's curse" hypothesis: mitochondrial DNA mutations harmful to males but neutral for females can accumulate in the population without being eliminated by natural selection.

Female mitochondria present different bioenergetic properties. Estrogens, notably estradiol, stimulate mitochondrial biogenesis via PGC-1α, improve respiratory chain efficiency, and reduce ROS production. These effects contribute to a less oxidative cellular environment in women of reproductive age.

The immune system: a female advantage with a double edge

Women develop more robust immune responses to infections and vaccinations. They produce more antibodies, have more active cytotoxic T lymphocytes, and present a more reactive innate immunity.

But this advantage has a cost: more than 80% of patients with lupus, rheumatoid arthritis, multiple sclerosis or Hashimoto's thyroiditis are women.

The aging of the immune system (immunosenescence) takes different forms depending on sex, with distinct consequences on inflammaging and resistance to chronic diseases.

Menopause, andropause and accelerated aging

Menopause: a biological turning point

Menopause marks the cessation of ovarian production of estradiol and progesterone. Estradiol exerts pleiotropic effects: cardiovascular protection, neuroprotective effects, stimulation of mitochondrial biogenesis, and modulation of epigenetic profiles. Its abrupt drop at menopause simultaneously destabilizes all these systems.

Several studies using Horvath and GrimAge clocks have shown that menopause is associated with an acceleration of epigenetic age — postmenopausal women present a statistically more advanced biological age than premenopausal women of the same chronological age.

NAD+ decline is also accelerated by menopause: estradiol stimulates the expression of NAMPT, the rate-limiting enzyme of NAD+ biosynthesis. Its drop contributes to the NAD+ depletion that characterizes post-menopausal female aging.

Andropause: a slower but continuous decline

In men, testosterone decline is progressive and begins as early as the thirties — approximately 1% per year. Its decline contributes to male sarcopenia, increased visceral adipose tissue and a progressive deterioration of the metabolic profile.

Sex differences in longevity signaling pathways

The IGF-1/insulin pathway presents significant sex differences documented in human centenarians.

AMPK and mTOR respond differently depending on hormonal sex — partly under the influence of estrogens and testosterone. These differences have consequences on the regulation of autophagy, mitochondrial biogenesis and protein synthesis.

Sirtuins present differences in expression and activity depending on sex, with SIRT1 being modulated by estrogens in several tissues.

Implications for sex-specific precision cellular nutrition

Biological sex is a scientifically unavoidable variable in any precision cellular nutrition approach oriented toward longevity.

NAD+ precursor needs are not identical before and after menopause. Oxidative pressures on mitochondria differ between a 45-year-old man and a 45-year-old woman in the perimenopausal period.

This is not a question of gendered marketing. It is a question of biology.

In conclusion

The longevity difference between men and women is the documented result of deep biological differences — chromosomal, mitochondrial, immune, epigenetic and hormonal — that operate at the cellular level throughout life.

Contemporary geroscience no longer treats biological sex as a confounding variable. It treats it as a central explanatory variable — whose understanding is indispensable to any precision intervention on aging.

References: Austad & Bartke, Cell Metabolism, 2016 · Mauvais-Jarvis et al., Nature Medicine, 2020 · Shi et al., Nature Aging, 2021 · Forsberg et al., Nature, 2022 · López-Otín et al., Cell, 2023

This article is published for informational and educational purposes only. It does not constitute medical advice and does not replace professional medical consultation.